A new major player in T cell suppression and tumor control
An inhibitory receptor binds a checkpoint protein to thwart T cell proliferation and function.
immune checkpoint inhibitors
Customizing mRNA vaccines for cancer
Researchers use mRNA to create cancer vaccines that are personalized to each individual’s unique tumor.
Combination therapy for cancer: using immunotherapy and viruses
How are scientists incorporating oncolytic viruses into the current cancer treatment landscape?
The dual role of microbiota in cancer immunotherapy
Understanding the complex three-way communication between immune cells, the gut microbiome, and cancer sheds light on why immunotherapies fail in some patients but succeed in others.
How gut microbes meddle with cancer immunotherapy
By investigating how gut bacteria influence immunotherapy responses in mice, researchers found a molecule involved in treatment resistance.
Advancing immune forces at the tumor frontlines
Epigenetic therapies revive the immune cell offensive in immunotherapy resistant tumors.
